Solesence Inc (SLSN) FinancialsSLSNSolesence Inc

Solesence Inc (SLSN) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Solésence, accounting for 77.4% of total sales, equivalent to $10.03M. Other significant revenue streams include Personal Care Ingredients and Advanced Materials. Understanding this composition is critical for investors evaluating how SLSN navigates market cycles within the Personal Products industry.

Evaluating the bottom line, Solesence Inc maintains a gross margin of 30.97%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 0.79%, while the net margin is -1.03%. These profitability ratios, combined with a Return on Equity (ROE) of -13.25%, provide a clear picture of how effectively SLSN converts its operational activities into shareholder value.

In the context of the broader market, SLSN competes directly with industry leaders such as GROV and AXIL. With a market capitalization of $61.24M, it holds a leading position in the sector. When comparing efficiency, SLSN's gross margin of 30.97% stands against GROV's 53.56% and AXIL's 82.62%. Such benchmarking helps identify whether Solesence Inc is trading at a premium or discount relative to its financial performance.

Solesence has shown fluctuating financial performance, with revenue growth in Q2 2026 reaching $15.3 million, but it still faces net losses, including a loss of $158,000 in Q2 2026. The gross margin has been improving, reaching 30.97% in Q2 2026, which is a positive sign for future profitability.